4/A: Omada Health Insider Sells Shares, Corrects Prior Filing

Omada Health President Wei-Li Shao has sold shares of common stock as part of a pre-arranged trading plan, with an amendment correcting the number of shares sold and beneficially owned.

Summary

• Wei-Li Shao, President of Omada Health, Inc., sold 4,037 shares of common stock on June 12, 2026.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on March 13, 2026.
• This filing is an amendment to a previous Form 4, correcting an administrative error by the broker that overstated the number of shares sold and the total beneficial ownership.
• The weighted average sale price was $17.2407, with individual trades ranging from $17.10 to $17.54.
• Following the corrected transaction, Shao beneficially owns 316,790 shares of Omada Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves insider selling, it is conducted under a pre-arranged plan and the primary purpose of the filing is to correct a previous administrative error, not to signal a change in the company's prospects.

Positives

• The filing clarifies a previous reporting error, ensuring accurate disclosure of insider transactions.
• The transaction was conducted under a pre-established 10b5-1 plan, indicating adherence to a structured and compliant trading strategy.

Negatives

• An insider, the President, has sold a portion of their holdings.
• The need for an amendment suggests an administrative or broker error, which could raise minor concerns about internal controls or communication.

Risks

• Potential for further administrative errors in reporting or execution of trades.
• Market perception of insider selling, even if pre-planned, can sometimes negatively influence stock price.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on a past transaction and corrects prior disclosures.

Management Comments

• The filing is an amendment to correct an administrative error by the broker regarding the number of shares sold and total beneficial ownership.
• The transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Industry Context

StockSavvy.ai notes that insider selling, particularly under a 10b5-1 plan, is a common occurrence in the healthcare technology sector as executives manage personal finances. The correction of a prior filing highlights the importance of meticulous reporting and broker diligence.

Stakeholder Impact

• Shareholders: May observe the insider sale, but the pre-planned nature and correction of error mitigate significant negative impact. The corrected ownership figures provide clarity.
• Employees: No direct impact indicated.
• Creditors: No direct impact indicated.
• Suppliers/Customers: No direct impact indicated.

Next Steps

• No specific next steps are outlined in this filing.
• The company will continue to operate under its existing business strategy.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, SEC Filing, President, Common Stock